Markers that predict omalizumab response identified

May 2, 2016

(HealthDay)—Baseline serum periostin levels and levels of serum free immunoglobulin E (IgE) during treatment follow-up may be useful in assessing response to omalizumab treatment for asthma, according to a study published online April 26 in Allergy.

Tomoko Tajiri, from Kyoto University in Japan, and colleagues assessed the utility of biomarkers of type 2 inflammation (free serum IgE levels) in predicting omalizumab responses. Response was defined as the absence of asthma exacerbation during the first year of treatment. The study included 30 patients who were treated with omalizumab for at least one year, with 27 of them treated for two years.

The researchers found that patients without exacerbations during the first year of treatment had significantly higher baseline serum periostin levels and blood eosinophil counts than patients with exacerbations. There was a negative association between baseline serum periostin levels, but not eosinophil counts, and free serum IgE levels after 16 or 32 weeks of treatment. Reduced exacerbation numbers at two years were seen in those with reduced free serum IgE levels during treatment. For the 14 who had exacerbations during the first year of treatment, exacerbation numbers gradually and significantly decreased over the two-year study period, with simultaneous significant reductions in free serum IgE levels.

"Baseline serum periostin levels and serum free IgE levels during treatment follow-up may be useful in evaluating responses to omalizumab treatment," conclude the authors.

Several authors report financial ties to the pharmaceutical industry. One author disclosed a patent application for serum periostin for treatment of bronchial asthma.

Explore further: Preventive topical steroids cut atopic dermatitis severity

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Preventive topical steroids cut atopic dermatitis severity

April 28, 2016
(HealthDay)—Intermittent preventive administration of topical corticosteroids in children controls the severity of atopic dermatitis (AD), according to a study published online April 14 in the Journal of Dermatology.

Omalizumab decreases colds in inner-city children with asthma, study reports

March 6, 2016
Treatment with omalizumab significantly decreases the number of colds in inner-city children with allergic asthma, researchers reported at a press conference today at the American Academy of Allergy, Asthma and Immunology ...

Elevated carcinoembryonic antigen described in anorexia

March 30, 2016
(HealthDay)—In a case report published online March 25 in the International Journal of Eating Disorders, elevated serum carcinoembryonic antigen (CEA) levels are observed in a male patient with anorexia nervosa (AN).

Vitamin D deficiency ups odds of asthma exacerbation

December 5, 2014
(HealthDay)—Vitamin D deficiency is associated with increased odds of asthma exacerbations, according to a study published in the December issue of Allergy.

Investigational treatment provides hope for some chronic liver disease sufferers

April 16, 2016
A new study presented today provides hope for a new treatment in patients with primary sclerosing cholangitis, a rare condition characterised by inflammation and scarring in the bile ducts of the liver and for which there ...

Serotonin levels low in ankylosing spondylitis

October 3, 2015
(HealthDay)—Patients with ankylosing spondylitis (AS) have lower serotonin levels than healthy controls and patients with rheumatoid arthritis (RA), according to a study published online Sept. 30 in the Journal of Bone ...

Recommended for you

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

Faecal transplants, 'robotic guts' and the fight against deadly gut bugs

December 13, 2018
A simple compound found in our gut could help to stop dangerous bacteria behind severe, and sometimes fatal, hospital infections.

Taking the virus out of a mosquito's bite

December 12, 2018
They approach with the telltale sign—a high-pitched whine. It's a warning that you are a mosquito's next meal. But that mosquito might carry a virus, and now the virus is in you. Now, with the help of state-of-the-art technology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.